[1]: Coppé, J. P., et al. (2010). The senescence-associated secretory phenotype: the dark side of tumor suppression. *Aging Cell*, 9(2), 223–235.
[2]: Victorelli, S., et al. (2022). Apoptotic stress causes mtDNA release during senescence and drives the SASP. *Nature*, 622(7931), 627–636.
[3]: Palmer, A. K., et al. (2020). Targeting senescent cells alleviates obesity-induced metabolic dysfunction. *Cell Metabolism*, 32(1), 87–99.
[4]: Lee, J. H., et al. (2024). Senescent hepatocytes drive age-related immune decline via Galectin-9. *Science Immunology*, 9(94), eadf1002.
[5]: Dehkordi, M. H., et al. (2023). In vivo imaging of SASP factors in human Alzheimer’s disease brains. *Nature Aging*, 3(5), 545–560.
[6]: Roos, C. M., et al. (2021). Chronic senolytic treatment alleviates established atherosclerosis in mice. *European Heart Journal*, 42(35), 3547–3560.
[7]: Ogrodnik, M., et al. (2019). Obesity-induced senescent cells promote metabolic dysfunction. *Nature Medicine*, 25(12), 1852–1858.
[8]: Zhu, Y., et al. (2015). The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs. *Aging Cell*, 14(4), 644–658.
[9]: Yousefzadeh, M. J., et al. (2018). Fisetin is a senotherapeutic that extends health and lifespan. *EBioMedicine*, 36, 18–28.
封面报道|细胞的阴谋:细胞衰老如何引爆全身慢性炎症?
[10]: Hickson, L. J., et al. (2023). Senolytics in diabetic kidney disease: a randomized controlled trial. *The Lancet Healthy Longevity*, 4(3), e129–e140.
[11]: Cheah, I. K., & Halliwell, B. (2021). Ergothioneine, recent developments. *Redox Biology*, 42, 101868.
[12]: Kiecolt-Glaser, J. K., et al. (2022). Omega-3 supplementation lowers inflammation and anxiety in medical students: a randomized controlled trial. *Clinical Nutrition*, 41(1), 156–164.
[13]: Amor, C., et al. (2024). Senolytic CAR T cells reverse senescence-associated pathologies. *Science*, 383(6683), eabe7892.